Shilpa Medicare

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE790G01031
  • NSEID: SHILPAMED
  • BSEID: 530549
INR
850.50
-50.4 (-5.59%)
BSENSE

Nov 20

BSE+NSE Vol: 16.58 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Net Sales
529.12
465.78
436.99
410.28
369.97
321.46
330.82
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
529.12
465.78
436.99
410.28
369.97
321.46
330.82
Raw Material Cost
191.87
144.54
127.57
100.75
127.64
115.04
85.51
Purchase of Finished goods
9.43
8.45
6.98
7.14
7.36
4.16
6.29
(Increase) / Decrease In Stocks
-12.42
-17.84
7.44
25.43
-29.50
-39.59
12.69
Employee Cost
96.83
99.71
86.56
83.46
83.05
81.81
70.93
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
101.01
94.65
88.73
78.65
73.14
68.40
76.19
Total Expenditure (Excl Depreciation)
386.72
329.51
317.28
295.43
261.69
229.82
251.61
Operating Profit (PBDIT) excl Other Income
142.40
136.27
119.71
114.85
108.28
91.64
79.21
Other Income
8.64
3.13
1.67
0.26
1.75
6.38
7.63
Operating Profit (PBDIT)
151.04
139.40
121.38
115.11
110.03
98.02
86.84
Interest
12.68
12.10
13.66
10.68
15.67
18.78
14.49
Exceptional Items
-0.43
0.00
25.02
-12.86
0.00
0.00
-30.59
Gross Profit (PBDT)
137.93
127.30
132.74
91.57
94.36
79.24
41.76
Depreciation
34.29
35.20
30.62
30.36
29.82
28.92
28.79
Profit Before Tax
103.53
98.06
120.44
60.85
64.43
49.58
15.27
Tax
24.35
-2.82
12.65
16.27
20.36
2.69
0.76
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
79.29
94.92
89.47
44.94
44.18
47.62
12.21
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
79.29
94.92
89.47
44.94
44.18
47.62
12.21
Share in Profit of Associates
-0.11
5.96
18.32
-0.36
-0.11
-0.73
2.30
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
79.18
100.88
107.79
44.58
44.07
46.89
14.51
Equity Capital
19.56
19.56
19.56
19.56
9.78
9.78
19.56
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
4.05
5.16
5.51
2.28
2.25
2.4
0.37
Diluted Earnings per share
4.05
5.16
5.51
2.28
2.75
2.4
0.37
Operating Profit Margin (Excl OI)
26.91%
29.26%
27.39%
27.99%
29.27%
28.51%
23.94%
Gross Profit Margin
26.07%
27.33%
30.38%
22.32%
25.5%
24.65%
12.62%
PAT Margin
14.96%
21.66%
24.67%
10.87%
11.91%
14.59%
4.39%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2026 is 13.60% vs 6.59% in Jun 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2026 is -21.51% vs -6.41% in Jun 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2026 is 4.50% vs 13.83% in Jun 2026

stock-summary

Interest

QoQ Growth in quarter ended Sep 2026 is 4.79% vs -11.42% in Jun 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026

Compare Quarterly Results Of Shilpa Medicare With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
529.12
516.24
12.88
2.49%
Other Operating Income
0.00
0.00
0.00
Total Operating income
529.12
516.24
12.88
2.49%
Raw Material Cost
191.87
152.25
39.62
26.02%
Purchase of Finished goods
9.43
0.00
9.43
(Increase) / Decrease In Stocks
-12.42
-4.82
-7.60
-157.68%
Employee Cost
96.83
77.58
19.25
24.81%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
101.01
127.94
-26.93
-21.05%
Total Expenditure (Excl Depreciation)
386.72
352.95
33.77
9.57%
Operating Profit (PBDIT) excl Other Income
142.40
163.29
-20.89
-12.79%
Other Income
8.64
0.95
7.69
809.47%
Operating Profit (PBDIT)
151.04
164.24
-13.20
-8.04%
Interest
12.68
34.56
-21.88
-63.31%
Exceptional Items
-0.43
-1.77
1.34
75.71%
Gross Profit (PBDT)
137.93
127.91
10.02
7.83%
Depreciation
34.29
75.05
-40.76
-54.31%
Profit Before Tax
103.53
52.87
50.66
95.82%
Tax
24.35
-4.62
28.97
627.06%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
79.29
57.48
21.81
37.94%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
79.29
57.48
21.81
37.94%
Share in Profit of Associates
-0.11
0.00
-0.11
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
79.18
57.48
21.70
37.75%
Equity Capital
19.56
11.47
8.09
70.53%
Face Value
1.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
4.05
5.01
-0.96
-19.16%
Diluted Earnings per share
4.05
5.01
-0.96
-19.16%
Operating Profit Margin (Excl OI)
26.91%
31.63%
0.00
-4.72%
Gross Profit Margin
26.07%
24.78%
0.00
1.29%
PAT Margin
14.96%
11.13%
0.00
3.83%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 529.12 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 13.60% vs 6.59% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 43.02% vs 7.61% in Sep 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 79.18 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -21.51% vs -6.41% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 79.67% vs 145.65% in Sep 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 142.40 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 4.50% vs 13.83% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 31.51% vs 25.91% in Sep 2025

Quarterly - Interest
Interest 12.68 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 4.79% vs -11.42% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is -19.08% vs -38.67% in Sep 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 26.91%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025